World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
113
Citations
48406
World Ranking
4944
National Ranking
487

Overview

Ghulam J. Mufti is affiliated with King's College London in the United Kingdom. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a particular emphasis on Hematology, Genetics, and Molecular Biology. Additional areas include Oncology and Immunology.

Their main research topics encompass Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Hemoglobinopathies and Related Disorders, Hematopoietic Stem Cell Transplantation, Blood groups and transfusion, RNA modifications and cancer, and Immunodeficiency and Autoimmune Disorders.

Frequently published venues for their work include Blood, eLife, Clinical Lymphoma Myeloma & Leukemia, Leukemia, and the New England Journal of Medicine.

Frequent coauthors in their research collaborations include Valeria Santini, Pierre Fenaux, Guillermo Garcia-Manero, Mikkael A. Sekeres, and Uwe Platzbecker.

Notable recent publications include:

  • Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes, 2020, New England Journal of Medicine
  • Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia, 2022, New England Journal of Medicine
  • Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience, 2020, British Journal of Haematology
  • Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia, 2021, Leukemia
  • Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipients, 2020, Journal of Clinical Virology

Best Publications

  • International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

    Peter Greenberg;Christopher Cox;Michelle M. LeBeau;Pierre Fenaux

  • Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.

    Pierre Fenaux;Ghulam J. Mufti;Eva Hellstrom-Lindberg;Valeria Santini

  • Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia

    Pierre Fenaux;Ghulam J. Mufti;Eva Hellström-Lindberg;Valeria Santini

  • 'Off-the-shelf' allogeneic CAR T cells: development and challenges.

    S Depil;Philippe Duchateau;S A Grupp;G Mufti

  • Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

    Luca Malcovati;Eva Hellström-Lindberg;David Bowen;Lionel Adès

  • Guidelines for the diagnosis and management of adult aplastic anaemia.

    Sally B Killick;Nick Bown;Jamie Cavenagh;Inderjeet Dokal

  • Myelodysplastic syndromes: a scoring system with prognostic significance

    G. J. Mufti;J. R. Stevens;D. G. Oscier;T. J. Hamblin

  • TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression

    Martin Jädersten;Leonie Saft;Alexander Smith;Austin Kulasekararaj

  • A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q

    Pierre Fenaux;Aristoteles Giagounidis;Dominik Selleslag;Odile Beyne-Rauzy

  • Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

    Rodrigo Martino;Simona Iacobelli;Ronald Brand;Thekla Jansen

  • The role of apoptosis, proliferation, and the Bcl-2–related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS

    Jane E. Parker;Ghulam J. Mufti;Feyrooz Rasool;Aleksandar Mijovic

  • Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

    Pierre Fenaux;Pierre Fenaux;Uwe Platzbecker;Ghulam J. Mufti;Guillermo Garcia-Manero

  • Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes.

    David Bowen;Dominic Culligan;Simon Jowitt;Stephen Kelsey

  • Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts

    Ghulam J. Mufti;John M. Bennett;Jean Goasguen;Barbara J. Bain

  • Clonal Analysis of Myelodysplastic Syndromes: Evidence of Multipotent Stem Cell Origin

    J. W. G. Janssen;M. Buschle;M. Layton;H. G. Drexler

  • Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

    Theo De Witte;David Bowen;Marie Robin;Luca Malcovati

  • Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia

    ZiYi Lim;Ronald Brand;Rodrigo Martino;Anja van Biezen

  • Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells.

    Abdelkader Essafi;Silvia Fernandez De Mattos;Yasmin A. M. Hassen;Ines Soeiro

  • Prevalence of the Activating JAK2 Tyrosine Kinase Mutation V617F in the Budd-Chiari Syndrome

    Raj K. Patel;Nicholas C. Lea;Michael A. Heneghan;Nigel B. Westwood

  • Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres

    David J. Kuter;Barbara Bain;Ghulam Mufti;Adam Bagg

Frequent Co-Authors

Judith C. W. Marsh
Judith C. W. Marsh King's College London
Pierre Fenaux
Pierre Fenaux Université Paris Cité
Farzin Farzaneh
Farzin Farzaneh King's College London
Alan F. List
Alan F. List Precision BioSciences
Eva Hellström-Lindberg
Eva Hellström-Lindberg Karolinska University Hospital
Guillermo Sanz
Guillermo Sanz Hospital Universitari i Politècnic La Fe
Arnon Nagler
Arnon Nagler Sheba Medical Center
Mikkael A. Sekeres
Mikkael A. Sekeres Cleveland Clinic
John F. Seymour
John F. Seymour Peter MacCallum Cancer Centre
Dietger Niederwieser
Dietger Niederwieser Leipzig University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative health-related careers in the USA can open up a wide range of opportunities beyond traditional medical school. Many students consider online programs for greater flexibility, affordability, and faster entry into the workforce.

For those interested in health data, numerous online schools for health information management offer programs where you can learn to maintain and secure vital patient records. If you prefer the administrative side of healthcare, you may wonder, how much does it cost to become a medical coder? Online coding programs are often cost-effective and can lead to solid career prospects in a short time.

Nursing is another high-demand field. Some seek out the cheapest online nurse practitioner programs to advance their careers while managing costs. For those beginning their journey, it’s also important to understand how much does online nursing school cost. These online pathways make healthcare careers more accessible to a wider range of students.

Best Scientists Citing Ghulam J. Mufti

Trending Scientists

Recently Published Articles